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Figure 1. Diffuse, indurated, partly fluctant, purplish swelling 
of right hemifacial
Figure 2. Chromobacterium violaceum growing on agar
Chromobacterium violaceum is a Gram-
negative facultatively anaerobic, oxidase-
positive bacterium producing a dark violet 
antioxidant pigment called violacein. It is an 
opportunistic pathogen and has an ubiquitous 
distribution, mainly resides in water and soil of 
tropical and subtropical regions.1-3
An-18-year-old man referred to the 
emergency room with a 5-day history of 
progressively worsening swelling of the right 
cheek. He sought consult and hospitalized at 
another institution for three days prior this 
admission; however, his condition deteriorated. 
He had a history of having abscesses several 
time. Four month before this visit, he was also 
admitted in our hospital due to an abscess in 
the right thigh. Pus and blood culture were 
positive for Staphylococcus haemolyticus, 
with a total serum IgE of 2493.0 IU/ml. He 
recovered completely after being treated with 
vancomycin in this event. He had neither diabetes 
mellitus nor human immunodeficiency virus 
infection history. In this presentation, he was in 
a critically ill state with septic shock. Physical 
examination revealed diffuse, indurated, partly 
fluctuant, and some deep purple area of right 
hemifacial swelling. It was extended anteriorly 
from angle of mouth to retroauricular, superiorly 
from superior palpebra to lower border of 
mandible (Figure 1). Laboratory studies were 
notable for a white-cell count of 12,970/mm3 
(total lymphocyte count 778.2), platelet count 
96,000/mm3. The patient got norepinephrine drip 
and broad-spectrum antibiotic intravenously. 
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He also underwent superficial drainage of the 
abscess. Unfortunately, the patient eventually 
succumbed. Sample from right submandibular 
abscess showed no growth, but blood sample 
was confirmed to grow C. violaceum (Figure 2). 
It showed sensitivity to ciprofloxacin, amikacin, 
cotrimoxazole, chloramphenicol, tetracycline.
Since it was firstly described in 1927, only a 
few cases of human infection with C. violaceum 
have been reported.2,4-6 As shown in our case, the 
classical clinical manifestation was localized 
soft tissue infection which rapidly progressed 
to fulminant sepsis with a high mortality rate.1,6,7 
A defect in host defense system might be the 
predisposing factor for this kind of infection in 
our case. As this is such a rare infection, there 
is no guideline on the choice of antibiotics or 
duration of treatment at present. Successful 
treatment is most likely due to early recognition, 
prompt surgical drainage and appropriate 
antibiotic.2,3,5 To the best of our knowledge, this is 
the first reported case from Indonesia that could 
be identified in the literature.
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